Literature DB >> 11385186

Helicobacter pylori infection and coronary heart disease in Japanese patients.

H Osawa1, M Kawakami, M Fujii, N Kubo, H Iwanaka, W Yamamoto, M Saitoh, T Yaginuma, K Sugano.   

Abstract

Although several independent studies have claimed a link between Helicobacter pylori infection and coronary heart disease (CHD), this association has not been established conclusively. The aim was to determine whether an association between H. pylori infection and CHD can be demonstrated in Japanese patients. Three-hundred and four patients who underwent consecutive coronary arteriography were investigated. Ninety-four patients had single-vessel coronary stenosis and 112 had multi-vessel stenosis. The remaining 98 patients had no significant stenosis in any coronary arteries. H. pylori infection was diagnosed serologically and the association between infection and CHD was estimated by the odds ratio. The serum pepsinogen (PG) I-II ratio was used to estimate the degree of gastric atrophy. Seropositivity for H. pylori was significantly higher in the patients with CHD (67%) than in the controls (50%; p = 0.006). The odds ratio for CHD after having H. pylori infection was estimated as 1.35 (95% confidence interval 1.03-1.78; p = 0.028), after adjustment for the common risk factors of CHD in a logistic regression analysis. The association between CHD and H. pylori infection was more significant among patients without any history of diabetes or smoking. The PG I-II ratio in H. pylori-positive patients was significantly higher in the multi-vessel group (3.46) than in the control or single-vessel group (2.86, p = 0.030; 2.78, p = 0.008; respectively). H. pylori infection was shown to be an independent risk factor for CHD in Japanese patients, especially among those who did not have a history of diabetes or smoking. These data imply that the association between H. pylori infection and CHD is clinically relevant. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2001        PMID: 11385186     DOI: 10.1159/000047337

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

1.  Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population.

Authors:  Yasuaki Saijo; Megumi Utsugi; Eiji Yoshioka; Tomonori Fukui; Fumihiro Sata; Naoki Nakagawa; Naoyuki Hasebe; Takahiko Yoshida; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2009-03-17       Impact factor: 3.674

2.  Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A meta-analysis.

Authors:  Xin-Juan Yu; Xuan Yang; Lei Feng; Li-Li Wang; Quan-Jiang Dong
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

3.  Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

Authors:  Ju Yup Lee; Nayoung Kim; Min Soo Kim; Yoon Jin Choi; Jung Won Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

4.  Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults.

Authors:  Hiroko Nakagawa; Takashi Tamura; Yoko Mitsuda; Yasuyuki Goto; Yoshikazu Kamiya; Takaaki Kondo; Kenji Wakai; Nobuyuki Hamajima
Journal:  Mediators Inflamm       Date:  2013-12-22       Impact factor: 4.711

Review 5.  Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer.

Authors:  Andreea Ligia Dincă; Lorena Elena Meliț; Cristina Oana Mărginean
Journal:  Children (Basel)       Date:  2022-07-20

6.  Atrophic gastritis is associated with coronary artery disease.

Authors:  Takafumi Senmaru; Michiaki Fukui; Muhei Tanaka; Masaaki Kuroda; Masahiro Yamazaki; Yohei Oda; Yuji Naito; Goji Hasegawa; Hitoshi Toda; Toshikazu Yoshikawa; Naoto Nakamura
Journal:  J Clin Biochem Nutr       Date:  2012-03-03       Impact factor: 3.114

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.